Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Strong epidemiologic evidence suggests an association between Alzheimer disease (AD) and type 2 diabetes. To determine if amyloid beta (A$\beta$) and hyperphosphorylated tau occurs in type 2 diabetes, pancreas tissues from 21 autopsy cases (10 type 2 diabetes and 11 controls) were analyzed. APP and tau mRNAs were identified in human pancreas and in cultured insulinoma beta cells (INS-1) by RT-PCR. Prominent APP and tau bands were detected by Western blotting in pancreatic extracts. Aggregated A$\beta$, hyperphosphorylated tau, ubiquitin, apolipoprotein E, apolipoprotein(a), IB1/JIP-1 and JNK1 were detected in Langerhans islets in type 2 diabetic patients. A$\beta$ was co-localized with amylin in islet amyloid deposits. In situ beta sheet formation of islet amyloid deposits was shown by infrared microspectroscopy (SIRMS). LPS increased APP in non-neuronal cells as well. We conclude that A$\beta$ deposits and hyperphosphorylated tau are also associated with type 2 diabetes, highlighting common pathogenetic features in neurodegenerative disorders, including AD and type 2 diabetes and suggesting that A deposits and hyperphosphorylated tau may also occur in other organs than the brain.


Published in:
Neurobiology of Aging, 31, 9, 1503-1515
Year:
2010
Publisher:
Elsevier
ISSN:
0197-4580
Keywords:
Laboratories:




 Record created 2010-07-22, last modified 2018-09-13

n/a:
Download fulltextPDF
External link:
Download fulltextURL
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)